Key Takeaways
- Multivitamin aging breakthrough — A landmark COSMOS trial published in Nature Medicine found that daily multivitamin use slowed biological aging by approximately four months over two years, with the greatest benefits in those who were biologically older at baseline.
- Lonza's $3 billion divestiture reshapes the supply chain — Lone Star Funds will acquire Lonza's Capsules & Health Ingredients division for CHF 2.3 billion, creating a standalone nutraceutical and pharma capsule business under private equity ownership.
- Expo West 2026 signals the GLP-1 era — With 22 percent of US households now having at least one person on a GLP-1 medication, the supplement industry is rapidly pivoting toward formulations that support metabolic health, gut function, and nutrient density for this growing consumer base.
- FDA to revisit DSHEA ingredient definitions — A public meeting on March 27 will examine how proteins, enzymes, and microbials are classified under DSHEA, with implications for precision fermentation and cell-culture derived ingredients.
- Cellular health and beauty supplements outpace the market — Beauty supplements are growing at 6 percent annually versus 2 percent for overall consumer health, while cellular health ingredients like NAD+ precursors and CoQ10 are emerging as the next major functional trend.
Top Stories
A landmark clinical trial published in Nature Medicine has delivered what may be the most broadly significant supplement finding in years. Researchers from Harvard and Mass General Brigham, analysing data from 958 participants in the COcoa Supplement and Multivitamin Outcomes Study (COSMOS), found that daily multivitamin use slowed biological aging by approximately four months over a two-year period. The study measured five epigenetic clocks — molecular markers of DNA methylation that track the pace of aging — and observed statistically significant slowing in the two clocks most predictive of mortality. Notably, participants who were biologically older than their chronological age at baseline benefited the most. Senior author Howard Sesso, a preventive medicine specialist at Mass General and epidemiologist at the Harvard T.H. Chan School of Public Health, said the results "open the door to learning more about accessible, safe interventions that contribute to healthier, higher-quality aging." The study used Centrum Silver as the test multivitamin and has been covered extensively by The Guardian, NBC News, Scientific American, and Business Insider. Nature Medicine | Harvard Gazette
In a deal that reshapes the global capsule and nutraceutical ingredient supply chain, Lone Star Funds has entered into a definitive agreement to acquire the Capsules & Health Ingredients (CHI) division of Lonza Group for an enterprise value of CHF 2.3 billion (approximately USD 3 billion). Lonza will receive upfront proceeds of USD 2.2 billion and retain a 40 percent equity position in the business. The transaction, with debt financing led by Goldman Sachs, Jefferies, and UBS, will position CHI as a standalone entity with dedicated investment and greater strategic flexibility across its pharma, nutraceutical, and active lifestyle markets. For Lonza, the divestiture marks the final step in its transformation into a pure-play contract development and manufacturing organisation (CDMO). Nutrition Insight | PitchBook
Natural Products Expo West 2026 wrapped up in Anaheim, California, with GLP-1 support, gut health, and functional snacking emerging as the dominant themes across the show floor. The natural and organic products industry has reached USD 342.1 billion in total sales. Kerry showcased its BC30 probiotic, citing a real-life study of 253 GLP-1 consumers that demonstrated improvements in gastrointestinal comfort. FrieslandCampina Ingredients presented protein-forward concepts combining prebiotics, probiotics, and whey protein to support the gut-muscle axis in GLP-1 users. ADM highlighted the potential of postbiotics to expand beyond capsules into beverages, snacks, and dairy formats. A striking statistic: 22 percent of US households now have at least one person on a GLP-1 medication. For those looking to support gut health through targeted supplementation, a high-quality multispore probiotic can complement the kind of microbiome-focused approach highlighted at the show. Nutrition Insight | The Food Institute
Business and Investment
The Lonza–Lone Star Funds transaction stands as the most significant M&A event in the supplement supply chain this quarter. By carving out the CHI division — which manufactures capsules and health ingredients for pharma and nutraceutical clients worldwide — Lonza is betting that its future lies entirely in biologics CDMO services. For the broader supplement industry, the creation of a standalone CHI entity under private equity ownership could accelerate investment in capsule innovation and ingredient development.
United Natural Foods, Inc. (UNFI) reported its second-quarter fiscal 2026 results, posting net sales of USD 7.9 billion — a 2.6 percent year-over-year decline. Despite the top-line contraction, the natural and organic products distributor delivered a 23.4 percent increase in adjusted EBITDA to USD 179 million and generated USD 283 million in net cash from operating activities, signalling improved operational efficiency. UNFI Investor Relations
In European pharma-nutraceutical consolidation, PharmaPath has completed its acquisition of Innovis Pharma, creating a fully integrated Greek pharmaceutical group with more than 450 employees spanning R&D, manufacturing, and commercial operations. Investors in Healthcare
Novella Innovative Technology has appointed Antonio Martinez Descalzo as CEO to lead the biotech company's transition from R&D to full-scale commercial operations. Novella's AuraCell precision-cultivation platform grows bioactive botanical compounds from plant cells in controlled environments, and the company is preparing for the commercial launch of its first product, Novella Strawberry, in 2027. PR Newswire
Science and Research
The COSMOS multivitamin trial represents a major milestone for the supplement evidence base. Published in Nature Medicine on March 9, the randomised controlled trial provides the first large-scale evidence that a standard daily multivitamin can measurably slow epigenetic aging in older adults. An accompanying editorial noted that while the findings are "a major advance for the supplement field," the relationship between epigenetic clock measurements and practical aspects of aging requires further investigation. Nature Medicine Editorial
A new study published in the Journal of the International Society of Sports Nutrition found that Givaudan's TurmiPure Gold turmeric extract supported exercise recovery within 24 hours. In a trial of 45 healthy subjects who took 300 mg of the extract daily for five days, male participants showed significant improvements in strength and work capacity within 24 hours of exercise-induced muscle damage, with reduced soreness at 72 hours. The findings add to the growing body of evidence supporting curcumin-based ingredients for sports nutrition applications — a benefit that consumers can also access through a well-formulated curcumin supplement. Nutraceuticals World
Researchers at the University of Tuscia and 3trees Healthcare have published findings in Frontiers in Nutrition demonstrating that a novel nutraceutical combination of vitamin A, selenium, taurine, oleic acid, and resveratrol completely prevented the inflammation-induced downregulation of the selenoenzyme DIO1, which is crucial for thyroid hormone activation. The in vitro study suggests that targeted nutrient combinations could support metabolic resilience under inflammatory conditions. Frontiers in Nutrition
New Product Launches and Formulation
Bragg has entered the metabolic health supplement space with a new Metabolism Support product that blends apple cider vinegar with hibiscus and lemon verbena extracts. The formulation is designed to naturally stimulate the body's GLP-1 release and support metabolism, positioning it within the rapidly growing category of supplements targeting GLP-1 pathways without the use of prescription medications. Nutrition Insight
Lallemand Bio-Ingredients has launched Re-Vaya, a new ingredient complex for metabolic health combining selenium, vitamin D, yeast beta-glucans, and zinc. According to the company, the blend helps create favourable shifts in the inflammatory and metabolic profile of visceral adipose tissue, supporting overall metabolic balance. Nutraceuticals World
Make Time Wellness, the supplement brand founded by Emma Heming Willis, has unveiled three new brain health products for women: Make Time for Menopause & Brain Health, Make Time for NAD+ & Rhodiola, and Make Time for Brain, Body, & Beauty Stick Packs. The formulations feature Cognizin Citicoline and are designed to support cognitive function, hormonal balance, and cellular energy. For those interested in cognitive support through evidence-based ingredients, Lion's Mane remains one of the most well-researched natural nootropics available. Yahoo Finance
Rousselot used Expo West 2026 to launch Byon, a beauty and performance beverage concept featuring its Nextida GC collagen peptide ingredient alongside Peptan. The product targets the convergence of beauty-from-within and sports nutrition. Nutritional Outlook
At the same show, Youtheory launched a new longevity line featuring NR (nicotinamide riboside) and liposomal glutathione formulations, reflecting the broader industry shift toward cellular health and longevity-focused supplementation.
Regulations and Quality
The US Food and Drug Administration has announced a public meeting scheduled for March 27, 2026, to gather stakeholder feedback on the definition of dietary ingredient categories under the Dietary Supplement Health and Education Act (DSHEA). Titled "Exploring the Scope of Dietary Supplement Ingredients," the meeting will focus specifically on proteins, enzymes, and microbials, with the agency seeking to clarify the meaning of "dietary substance for use by man to supplement the diet by increasing the total dietary intake." The FDA is also inviting discussion on how new production methodologies — including precision fermentation and cell-culture techniques — should be evaluated for existing ingredient categories. Nutraceutical Business Review
The North American Testing, Inspection, and Certification (TIC) market is projected to grow from USD 69.89 billion in 2025 to USD 79.10 billion by 2030, according to a new report from MarketsandMarkets. The medical and life sciences sector is the fastest-growing application segment, driven by increasingly stringent regulatory frameworks. MarketsandMarkets
Marketing and Consumer Trends
The beauty supplement category continues to outperform the broader consumer health market, according to a new Euromonitor report. The segment is projected to grow at 6 percent annually in 2025, compared with 2 percent for overall consumer health. The convergence of health and beauty is driving consumer demand for ingredients such as collagen, vitamin C, hyaluronic acid, and NAD+ precursors. Euromonitor
Cellular health is emerging as a major consumer trend for the 2026–2031 period, according to an analysis by Imbibe. Key ingredients driving the category include NAD+ precursors (NMN and NR), CoQ10, PQQ, and polyphenols. The trend is being fuelled by growing consumer awareness of longevity science and the desire for "meaningful nutrition" beyond basic vitamins and minerals. Imbibe
Social commerce reached USD 1.01 billion in supplement sales in 2025, representing 5.4 percent of the e-commerce channel and 1.4 percent of total industry revenue, according to data from the Nutrition Business Journal. TikTok has emerged as a particularly powerful platform for supplement product discovery, with influencer-driven trends often translating into purchases on Amazon and other retail channels. New Hope Network
About the Author
Ben Law is the Founder of Love Life Supplements, a UK-based supplement company committed to evidence-based formulations and full-spectrum transparency. With a background in sports science and nutrition, Ben built Love Life Supplements to bridge the gap between clinical research and accessible, high-quality supplementation. He writes daily on the supplement industry to keep professionals and consumers informed of the trends, science, and business developments shaping the market. Learn more about Ben.